Literature DB >> 35832669

Lessons Learnt from an 11-year Experience with Lymphatic Surgery and a Systematic Review of Reported Complications: Technical Considerations to Reduce Morbidity.

Pedro Ciudad1,2,3, Joseph M Escandón4, Oscar J Manrique4, Valeria P Bustos5.   

Abstract

Complications experienced during lymphatic surgery have not been ubiquitously reported, and little has been described regarding how to prevent them. We present a review of complications reported during the surgical management of lymphedema and our experience with technical considerations to reduce morbidity from lymphatic surgery. A comprehensive search across different databases was conducted through November 2020. Based on the complications identified, we discussed the best approach for reducing the incidence of complications during lymphatic surgery based on our experience. The most common complications reported following lymphovenous anastomosis were re-exploration of the anastomosis, venous reflux, and surgical site infection. The most common complications using groin vascularized lymph node transfer (VLNT), submental VLNT, lateral thoracic VLNT, and supraclavicular VLNT included delayed wound healing, seroma and hematoma formation, lymphatic fluid leakage, iatrogenic lymphedema, soft-tissue infection, venous congestion, marginal nerve pseudoparalysis, and partial flap loss. Regarding intra-abdominal lymph node flaps, incisional hernia, hematoma, lymphatic fluid leakage, and postoperative ileus were commonly reported. Following suction-assisted lipectomy, significant blood loss and transient paresthesia were frequently reported. The reported complications of excisional procedures included soft-tissue infections, seroma and hematoma formation, skin-graft loss, significant blood loss, and minor skin flap necrosis. Evidently, lymphedema continues to represent a challenging condition; however, thorough patient selection, compliance with physiotherapy, and an experienced surgeon with adequate understanding of the lymphatic system can help maximize the safety of lymphatic surgery. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).

Entities:  

Keywords:  intraoperative complications; lymph nodes; lymphatic vessels; lymphedema; postoperative complications; surgical procedures

Year:  2022        PMID: 35832669      PMCID: PMC9045509          DOI: 10.1055/s-0042-1744412

Source DB:  PubMed          Journal:  Arch Plast Surg        ISSN: 2234-6163


Recent developments in microsurgery and an improved understanding of the lymphatic system and the pathogenesis of lymphedema have prompted the introduction of novel surgical methods that offer physiologic surgical alternatives for the management of lymphedema. 1 2 For instance, lymphovenous anastomosis (LVA) has benefits including minimal invasiveness, optimal aesthetic outcomes, and lower costs in comparison to physical therapy; however, limited evidence reporting the clinical safety of LVA is currently available. 3 Although vascularized lymph node transfer (VLNT) has shown better long-term outcomes in terms of a greater likelihood of discontinuing compressive therapies, 1 when harvested from either the groin or supraclavicular region, iatrogenic lymphedema of the donor site can follow. 4 5 Although the omentum has provided an alternative for lymphatic tissue transfer, major concerns regarding donor site morbidity pose some obstacles to its ubiquitous use. 6 7 8 Excisional surgical techniques are also available. The most common techniques include suction-assisted lipectomy (SAL), radical reduction with perforator preservation (RRPP), the Homan procedure, and the Charles procedure. 9 These techniques are usually indicated for patients with moderate to advanced lymphedema, yielding a high success rate. Nevertheless, pain, infection, lymphatic fistulas, severe wound breakdown, ulceration, and aggravation of lymphedema have been reported. 9 10 Herein, we present a systematic review of complications reported during the surgical management of lymphedema and our experience with technical considerations to prevent potential complications of lymphatic surgery.

Methods

Literature Search Strategy

This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 11 A comprehensive search of the medical indices PubMed, Ovid MEDLINE and In-Process & Other Non-Indexed Citations, Cochrane CENTRAL, and SCOPUS was performed from database inception through November 2020. The search strategy was designed and conducted by J.M.E. using the following terms: “complications,” “lymphedema,” “lymphoedema,” “lymph node,” “transfer,” “vascularized,” “transplant,” “lymphaticovenular,” “lymphovenous,” “anastomosis,” “liposuction,” and “subcutaneous excision” (see Supplemental Digital Content 1 [available in the online version], which displays the search strategy used in different databases).

Study Selection

Studies were included if they reported complications of lymphatic surgery using a specific technique and were written in English. Studies were excluded if they did not report postoperative outcomes and complications, or if the postoperative evolution was explicitly reported to be uneventful. Studies reporting cases of genital lymphedema or lymphatic malformations were also excluded.

Data Pooling and Data Analysis

After duplicates were removed, two authors (J.M.E. and V.P.B.) independently screened the articles based on title and abstracts. Afterward, relevant studies underwent full-text assessment using the exclusion and inclusion criteria. Data extraction was performed independently by the same two authors. The variables selected to describe the studies included the following: author and year, type of study, cause of lymphedema, number of patients, age, lymphedema stage, duration of lymphedema, surgical technique, associated procedures, complications, and follow-up. Percentages in this review represented the proportion of the overall reported complications for each technique. Subsequently, several technical considerations on how to prevent complications of lymphatic surgery and the experience of the senior author (P.C.) were discussed based on the findings of this review.

Results

After implementing the aforementioned search strategy, 829 references were identified. After duplicates were removed, 454 studies were evaluated based on title and abstract, and 195 were deemed irrelevant. Following full-text assessment of the remaining 259 studies, 60 articles were incorporated for qualitative data analysis. Five additional references were added during data extraction ( Fig. 1 ).
Fig. 1

Preferred reporting items for systematic reviews and meta-analyses flow diagram.

Preferred reporting items for systematic reviews and meta-analyses flow diagram. Thirteen articles reporting surgical complications of LVA were identified (see Supplementary Table S1 [available in the online version], which displays an overview of the included studies). 12 13 14 15 16 17 18 19 20 21 22 23 A summary of the reported complications is exhibited in Table 1 . The most common complications reported were re-exploration of the anastomosis ( n  = 22, 36.6%), venous reflux ( n  = 15, 24.6%), cellulitis or abscess ( n  = 9, 14.75%), seroma formation ( n  = 4, 6.55%), and lymphatic fluid leakage ( n  = 2, 3.27%).
Table 1

Reported complications of lymphovenous anastomosis

ComplicationsNumberPercentage
Revision of the anastomosis2236.0
Venous reflux1524.6
Cellulitis or abscess914.75
Seroma46.55
Ecchymoses34.9
Recurrence23.27
Lymphatic fluid leakage23.27
Pneumonia11.63
Partial skin necrosis11.63
Pulmonary embolus11.63
Neurapraxia11.63
Thirty-nine studies reporting surgical complications of VLNT were identified (see Supplementary Table S2 [available in the online version], which displays an overview of the included studies). 13 22 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 The most common complications detailed after groin VLNT were donor site pain or numbness ( n  = 32, 26.8%), delayed wound healing ( n  = 16, 13.44%), seroma formation ( n  = 14, 11.76%), lymphatic fluid leakage ( n  = 12, 10.08%), venous congestion ( n  = 9, 7.56%), and iatrogenic lymphedema ( n  = 5, 4.2%). When using lateral thoracic VLNT, iatrogenic lymphedema ( n  = 4, 30.76%), cellulitis ( n  = 2, 15.38%), and seroma and hematoma formation ( n  = 2, 15.38%) were also commonly reported. In patients treated with submental VLNT, the most common complications were venous congestion ( n  = 16, 42.1%), marginal nerve pseudoparalysis ( n  = 8, 21.05%), and partial flap loss ( n  = 7, 18.42%). In patients treated with supraclavicular VLNT, the presence of a congestive skin paddle ( n  = 4, 16%), donor site infection ( n  = 4, 16%), partial necrosis of the skin paddle ( n  = 3, 12%), and chyle leak ( n  = 3, 12%) were predominantly described ( Table 2 ).
Table 2

Surgical complications of groin VLNT, supraclavicular VLNT, lateral thoracic VLNT, and submental VLNT

G-VLNTLT-VLNTSM-VLNTSC-VLNTNot specific (G-VLNT, LT-VLNT, and SM-VLNT)
ComplicationsNo.PercentageComplicationsNo.PercentageComplicationsNo.PercentageComplicationsNo.PercentageComplicationsNo.
Donor site pain or numbness3226.80Iatrogenic lymphedema430.76Revision surgery due to venous complication1642.10Congestion of the skin paddle416Donor site seroma6
Delayed wound healing1613.44Cellulitis215.38Marginal nerve pseudoparalysis821.05Donor site infection416Donor site infection6
Seroma1411.76Seroma or hematoma215.38Partial flap loss718.42Partial necrosis of the skin paddle and debridement312Donor wound dehiscence3
Lymphatic fluid leakage1210.08Wound dehiscence17.69Dehiscence of recipient site37.89Re-exploration312Recipient site infection3
Revision surgery due to venous complication97.56Revision of the anastomosis17.69Arterial insufficiency25.26Chyle leakage312Recipient site bleeding (on coumadin)1
Subclinical slower lymphatic flow in donor site limb65.04Temporary weakness of upper extremity17.69Intraoperative salvage procedure12.63Hematoma28Recipient site nonhealing wound1
Iatrogenic lymphedema54.20Donor site pain17.69Hematoma12.63Lymphatic fluid leakage28Recipient site hematoma1
Wound infection55.04Lymphocele17.69Salvage procedure14Recipient site wound dehiscence1
Partial necrosis of the skin paddle43.36Delayed wound healing14Local skin flap necrosis1
Abdominal hernia32.52Partial loss of STSG14
Lymphocele32.52Lymphocele14
Local skin flap necrosis21.68
Arterial insufficiency21.68
Testicular hydrocele10.84
Pulmonary embolus10.84
Flap failure10.84
Hematoma10.84
Wound dehiscence10.84

Abbreviations: G-VLNT, groin VLNT; LT-VLNT; lateral thoracic VLNT; SC-VLNT, supraclavicular VLNT; SM-VLNT, submental VLNT; STSG, split-thickness skin graft; VLNT, vascularized lymph node transfer.

Abbreviations: G-VLNT, groin VLNT; LT-VLNT; lateral thoracic VLNT; SC-VLNT, supraclavicular VLNT; SM-VLNT, submental VLNT; STSG, split-thickness skin graft; VLNT, vascularized lymph node transfer. Regarding intra-abdominal lymph node flaps, the incidence of incisional hernia ( n  = 9, 30%), hematoma formation ( n  = 5, 16.66%), and postoperative ileus ( n  = 3, 10%) were commonly reported after vascularized omental lymph node flap transfer. In patients treated with gastroepiploic VLNT, the presence of numbness or paresthesia ( n  = 8, 27.7%), delayed wound healing ( n  = 2. 16.6%), and recipient site lymphatic fluid leakage ( n  = 2, 11.1%) were commonly reported. The incidence of ventral hernia ( n  = 4, 30.76%), postoperative ileus ( n  = 4, 30.76%), and flap loss ( n  = 2, 15.38%) was frequently reported following jejunal VLNT ( Table 3 ).
Table 3

Surgical complications of gastroepiploic VLNT, jejunal VLNT, and the vascularized omental lymph node flap

VOLFGE-VLNTJ-VLNT
ComplicationsNumberPercentageNumberPercentageNumberPercentage
Incisional hernia930.00430.76
Hematoma516.6617.69
Ileus and NG replacement310.00430.76
Cellulitis310.0017.69
Aborted procedure due to quality of flap26.66
Pancreatitis26.66
Flap loss26.6615.55215.38
Seroma26.6615.55
Donor site infection13.33
Revision surgery due to venous complication15.55
Perioperative blood transfusion15.55
Recipient-site hyperesthesia15.55
Recipient-site lymphatic fluid leakage211.11
Delayed wound healing211.11
Recipient-site Paresthesia316.66
Anastomotic revision17.69

Abbreviations: GE-VLNT, gastroepiploic VLNT; J-VLNT, jejunal VLNT; NG, nasogastric; VLNT, vascularized lymph node transfer; VOLF, vascularized omental lymph node flap.

Abbreviations: GE-VLNT, gastroepiploic VLNT; J-VLNT, jejunal VLNT; NG, nasogastric; VLNT, vascularized lymph node transfer; VOLF, vascularized omental lymph node flap. Seven studies reporting surgical complications of SAL were documented (see Supplementary Table S3 [available in the online version], which displays an overview of the included studies). 6 56 57 58 59 A summary of the reported complications is exhibited in Table 4 . The most common complications reported were significant blood loss ( n  = 30, 30.30%), transient paresthesia of the limb ( n  = 32, 32.32%), contour irregularities ( n  = 13, 13.13%), skin necrosis ( n  = 6, 6.6%), and hematoma or seroma formation ( n  = 8, 8.8%).
Table 4

Reported complications of suction-assisted lipectomy

ComplicationsNumberPercentage
Transient paresthesia or numbness3232.32
Blood transfusion3030.30
Contour irregularities1313.13
Hematoma/seroma88.8
Skin necrosis66.6
Superficial abrasions due to compression garments22.2
Soft tissue infection22.2
Neurapraxia22.2
Pneumonia11.1
Wound dehiscence11.1
Fat necrosis11.1
Epidermolysis11.1
Eleven articles reporting complications after excisional procedures were identified (see Supplementary Table S4 [available in the online version], which displays an overview of the included studies). 10 60 61 62 63 64 65 66 67 An overview of the reported complications is presented in Table 5 . The most common complications reported after RRPP were soft-tissue infection ( n  = 6, 33.3%), numbness of the extremity ( n  = 6, 33.3%), and seroma and hematoma ( n  = 2, 11%). The most common complications described after the Charles procedure were recurrent episodes of soft-tissue infection ( n  = 19, 22.6%), scarring and eczematoid dermatitis ( n  = 13, 15.47%), graft loss requiring regrafting ( n  = 10, 11.9%), ulceration ( n  = 11, 13.09%), and significant perioperative blood loss ( n  = 8, 9.5%). The reported complications after the Homan procedure were delayed wound healing ( n  = 3, 50%) and skin flap necrosis ( n  = 3, 50%).
Table 5

Studies reporting surgical complications of excisional procedures

ComplicationsNumberPercentageNumberPercentageNumberPercentage
Charles procedureHoman procedureRRPP
Soft-tissue infection1922.61NRNR633.3
Ulceration1113.09NRNRNRNR
Wrinkled areas1011.9NRNRNRNR
Skin graft loss1011.9NRNRNRNR
Significant blood loss89.52NRNRNRNR
Eczematoid dermatitis22.38NRNRNRNR
NumbnessNRNRNRNR633.3
Hypertrophic scarring1113.09NRNRNRNR
Wound dehiscence67.14NRNRNRNR
Flap necrosis11.2350NRNR
Scar contracture22.38NRNRNRNR
Delayed wound healing44.76350422.2
SeromaNRNRNRNR15.5
HematomaNRNRNRNR15.5

Abbreviation: RRPP, radical reduction with perforator preservation.

Abbreviation: RRPP, radical reduction with perforator preservation.

Discussion

Multiple techniques are available for the surgical management of lymphedema, and several modifications have been implemented to the point that a combination of different techniques has been suggested to offer more comprehensive and better results. 6 37 38 68 Physiologic techniques improve lymphatic drainage by means of lymphaticovenous connections and subsequent lymphatic fluid shunting into the venous system, or by promoting lymphangiogenesis. 69 Among those procedures, LVA and VLNT are the most widely accepted. 38 69 However, excisional procedures address the solid component of lymphedema and are advantageous in more advanced stages. 37

Lymphovenous Anastomosis

LVA is recommended when volume reduction using physical therapy has been unsatisfactory, or when there is worsening limb function, persistent limb pain, and recurrent episodes of cellulitis. 69 Although some authors have established an exponential relationship between the number of LVAs per limb and the reduction of the limb's cross-sectional area, 70 other authors have not detected a significant association during long-term follow-up. 71 72 In this sense, it is collectively agreed that LVA has produced promising results for early-stage disease in carefully selected lymphedema patients. 73 However, long-term results are less encouraging in advanced lymphedema stages, probably due to permanent damage from an increased interstitial pressure, recurrent infections, and lack of the functional smooth muscle required to successfully impel the lymphatic fluid into recipient veins. 69 73 Therefore, late-stage lymphedema, when lymphatic vessels are sclerotic, is a relative contraindication for LVA. When lymphosclerosis is moderate or initial LVAs have been temporarily effective, additional LVAs are recommended. Since the first LVAs are normally performed on the medial surface of lymphedematous limbs along the saphenous or cephalic/basilic veins, it is recommended to perform further LVAs on the lateral aspect of limbs or on the medial aspect where the first LVAs were not performed. Ultimately, VLNT should be considered in stages where LVA is unlikely to be successful. 68

Vascularized Lymph Node Transfer

VLNT should be implemented in patients with minimal or no response to conservative treatment, when dermal fibrosis and sclerotic lymph vessels prevent from performing LVA, and when postoperative outcomes following LVA are unsatisfactory. In fact, VLNT seems to be most effective even before fibrotic changes are evident. 30 33 38 68 Various donor sites have been described for lymph node flap harvest such as the groin, submental, lateral thoracic, supraclavicular, gastroepiploic, jejunal, and ileocecal areas. 38 74 Nonetheless, despite the satisfactory results of all vascularized lymph node flaps (VLNFs), there are some apprehensions concerning recipient and donor site morbidity. 30 33 38

Groin Vascularized Lymph Node Transfer

The groin VLNF is commonly based on the superficial circumflex iliac artery (SCIA). However, the superficial inferior epigastric artery or a minor, unnamed medial branch of the femoral artery can be an alternative pedicle if the SCIA is unsuitable. 50 75 76 In this direction, the critical area medial to the femoral artery and inferior to the inguinal crease must be avoided during flap harvest to preserve the sentinel lymph nodes of the leg and avoid donor site lymphedema, 76 a common complication reported in several series. 22 43 52 54 Nevertheless, some anatomical landmarks may not necessarily correspond to the dynamics of the lymphatic system. 77 Therefore, the incorporation of reverse lymphatic mapping to guide lymph node flap procurement can maximize safety and reduce the risk of iatrogenic lymphedema. 77 If the SCIA is selected for arterial inflow and has an undersized pedicle and small caliber, to solve the anastomotic size discrepancy, the senior author (P.C.) recommends including a small “cuff” of 1 to 1.2 mm from the femoral artery at the origin of the SCIA. In this way, the risk of thrombosis secondary to the abrupt change in caliber at the anastomosis site is avoided and the surgeon can perform a less challenging microvascular anastomosis. 76 Furthermore, in the cases in which the vascular stump is too short or if the SCIA caliber progressively decreases toward its origin, the lateral part of the SCIA can be used to vascularize the flap in a retrograde manner. 76 Venous discrepancy is not uncommon; in these cases, dissection can be prolonged to include a branch of the greater saphenous vein or an alternative cutaneous vein with a larger caliber for venous anastomosis. 76 Finally, in the cases where a secondary debulking procedure is required or planned, it is recommended to use the deep venous system as recipient vessels, so that the anastomosis is not disturbed during further interventions. 76

Supraclavicular Vascularized Lymph Node Transfer

Solely in the case of right arm lymphedema, the left supraclavicular area is chosen; otherwise, it is advisable to harvest lymph nodes from the right neck to avoid the risk of severing the thoracic duct. 78 A skin paddle can be incorporated with the supraclavicular VLNF for soft-tissue coverage. 78 Nevertheless, it is recommended to avoid the integration of a cutaneous component, as perfusion is usually unpredictable ( Fig. 2 ). 6 26 In fact, the overlying skin was removed intraoperatively in 20% of a series of 23 supraclavicular VLNTs due to congestion in our previous study. 25
Fig. 2

Case of a supraclavicular vascularized lymph node transfer (VLNT). A patient with upper limb lymphedema who was managed using supraclavicular VLNT based on the transverse cervical vessels and a branch of the external jugular vein. ( A ) Intraoperative photograph. ( B ) A photograph at follow-up on postoperative day 10 exhibiting skin paddle congestion and partial skin necrosis of the transferred flap. EJV, external jugular vein; TCA, transverse cervical artery; TCV, transverse cervical vein.

Case of a supraclavicular vascularized lymph node transfer (VLNT). A patient with upper limb lymphedema who was managed using supraclavicular VLNT based on the transverse cervical vessels and a branch of the external jugular vein. ( A ) Intraoperative photograph. ( B ) A photograph at follow-up on postoperative day 10 exhibiting skin paddle congestion and partial skin necrosis of the transferred flap. EJV, external jugular vein; TCA, transverse cervical artery; TCV, transverse cervical vein. Significant variations in the vascular anatomy of the transverse cervical artery (TCA) are also common. 78 79 For instance, the TCA may be very small and further dissection toward its origin may be necessary. 78 79 An associated transverse cervical vein is also usually present, but it can vary in size. In this scenario, a branch of the external jugular vein can be integrated into the flap as a second vein to intensify venous outflow and prevent venous congestion, 78 a commonly reported complication. 26 78 Complete knowledge of the anatomy is also imperative when a supraclavicular VLNF is lifted off from the anterior scalene muscle to preserve the phrenic nerve; otherwise, ventilation can be compromised if the nerve is severed. 78 It is important to note that when a large lymphatic vessel is visualized along the surgical field and it cannot be preserved, careful ligation and anastomosis to a recipient vein must be accomplished, as in LVA. 78 Furthermore, to avoid lymphatic leakage from the donor site during flap harvest or the recipient site during inset, 25 30 punctilious use of micro-hemoclips to control small lymphatic vessels is mandatory ( Fig. 3 ). 25 78
Fig. 3

Case of persistent lymphatic fluid. After an initial incision, a lymphatic vessel was transected, and persistent lymphatic fluid was evident in a patient with primary lower extremity lymphedema.

Case of persistent lymphatic fluid. After an initial incision, a lymphatic vessel was transected, and persistent lymphatic fluid was evident in a patient with primary lower extremity lymphedema.

Lateral Thoracic Vascularized Lymph Node Transfer

The free axillary lymph node flap has been shown to significantly decrease the size of edematous limbs. 80 Interestingly, the lateral thoracic artery is absent in around 12.5% of sides, in which case, the thoracodorsal artery provides the vascular supply to those lymph nodes. 74 81 Harvest of the lateral thoracic nodes typically is not an option in patients with upper limb lymphedema, as doing so can further compromise the drainage of the ipsilateral affected arm, or if they have been removed during axillary dissection. 81 As with the other donor sites, reverse lymphatic mapping should be performed to minimize the risk of donor site lymphedema when harvesting the lateral thoracic nodes. 81 82

Submental Vascularized Lymph Node Transfer

The main concern with submental VLNT, apart from the conspicuous scar over the donor site, is the risk of marginal mandibular nerve injury. 32 To avoid peripheral nerve damage, a nerve stimulator should be used during meticulous microscopic dissection. 32 A platysma-sparing harvest technique is also useful during dissection to avoid asymmetry of the lower lip secondary to injury to the marginal mandibular nerve. 32 Moreover, outstanding knowledge of the anatomy is mandatory due to the anatomical variability in this region, as more challenging dissections may be required due to the divergent configuration of the artery and vein observed throughout the submandibular gland. 83 Case of combined lymphovenous anastomosis (LVA) and suction-assisted lipectomy. ( A ) Preoperative photograph. ( B ). Postoperative photograph on the second day of follow-up. ( C ) Zone of epidermolysis on postoperative day 21.

Intra-abdominal Vascularized Lymph Node Flaps

The omentum has been successfully reported as an alternative option to avoid iatrogenic lymphedema. 84 85 86 87 However, with this technique, significant recipient site complications were noted due to the extensive dissection required for flap inset. 84 In previous studies, the distribution of lymph nodes within the omentum has been principally identified around the right gastroepiploic vessels, rather than within the whole omentum. 88 89 Consequently, a 3-cm-wide omentum segment from the greater curvature comprising the right gastroepiploic vessels has been determined to have an adequate quantity of lymph nodes. 88 90 Since it excludes the rest of the omental tissue, the resulting flap is a relatively small flap; therefore, it can be placed in the distal extremity, significantly improving the cosmesis of the recipient site. Furthermore, when compared with other intra-abdominal pedicles, the right gastroepiploic artery (RGA) is chosen because of the straightforwardness of its exposure and access compared with its contralateral counterpart. Additionally, it has been well established that flap procurement using the RGA does not increase the risk of gastric ischemia or other intra-abdominal complications. 91 92 A laparoscopic approach allows faster harvest, reduced postoperative pain, shorter scars, faster return of bowel function, reduced adhesions, and decreased abdominal wall morbidity in comparison to the traditional open approach. 86 93 94 95 Nevertheless, complications such as injuries of the pedicle, partial graft necrosis, incisional hernia, peritonitis, injury to intra-abdominal organs, postoperative ileus or bowel obstruction, hemorrhage, pancreatitis, and wound infection have been reported in large series of laparoscopic omental flap harvest. 94 95 Previously, we reported a series of 32 patients undergoing gastroepiploic VLNT who did not encounter any donor site complication; however, in other series, the authors reported only the incidence of postoperative ileus in one patient and a case of pancreatitis in a patient with a history of pancreas divisum. 24 In this regard, the dissection of the RGA in the vicinity of the pancreas must be limited to avoid pancreatitis, but it seems that the overall morbidity is low. Another advantage is that the omental fat apron hanging from the transverse colon is left undisturbed with the gastroepiploic VLNT. In this way, the omental coverage of the intestine is maintained, the risk of adhesions is decreased, and the risk of transverse colon injury is diminished. Thus, as seen in this review, the reported donor site morbidity of the laparoscopic-assisted total omentum harvest is not comparable to that of the gastroepiploic VLNF. Finally, the abundance of lymph nodes of the gastroepiploic VLNF affords the distinctive opportunity to split the flap into two or even three units for a separate inset into two different limbs or different levels in the same extremity. 86 This avoids the potential complications of a second donor site and also reduces the flap harvest time. 86 The jejunal mesentery is ideal as a donor site, as no risk of subsequent lymphedema is present and the vascular anatomy is reliable. Peripherally located lymph nodes are usually preferred due to their favorable hemodynamics, as they appear to have better balance of arterial inflow and venous outflow when compared with flaps raised closer to the root of the mesentery. 5 An important detriment of the jejunal VLNT is its segmental blood supply. Therefore, any poorly vascularized bowel segment would depend merely on the collateral circulation within the bowel wall, which may lead to partial bowel necrosis, resulting in bacterial translocation and subsequent infection. 88 96 Moreover, because of the more intense manipulation of the intestines during flap harvest, perioperative ileus and prolonged nasogastric tube decompression in the short term and a higher risk of small bowel obstruction in the long run would be expected. 88

Suction-Assisted Lipectomy

In comparison to lymphedematous limbs with a predominant fluid component, which may be treated with physiologic procedures such as LVA and VLNT; SAL is preferably used in the cases where the solid component is predominant, as it targets the trophic changes of the subcutaneous tissue. Additionally, SAL is usually used in patients with mild fibrosis or minor trophic skin changes, in whom the previous use of a physiologic procedure has not provided symptomatic relief and the disease seems to progress after a considerable follow-up period. 68 SAL seems to be a favorable treatment option in comparison to excisional surgery, as it avoids large incisions that have a higher risk of infection or scarring. 97 However, although SAL is able to provide effective symptomatic relief, patients must adhere to strict lifelong compression therapy as liposuction does not address lymphostasis. 98 Therefore, the addition of a physiologic procedure may become necessary for a comprehensive surgical management. In a previous report, we used LVA in combination with SAL and accomplished an average mean circumference reduction rate of 90 and 85% for upper extremity and lower extremity lymphedema, respectively, indicating the positive effect of this dual integrated therapy. 6 The use of the ultrasound lipoplasty device, VASER, improves the surgical effectiveness of SAL as it ruptures the fibrotic tissue and septa while also preserving vascularization and lymphatic vessels. 6 This device also includes multiple rings that disperse the energy, decreasing the thermal injury produced by the acoustic waves of the cannula. 6 Additionally, with a tumescent technique and an optimal tourniquet, the thermal injury is reduced even more while vasoconstriction avoids significant blood loss. 6 58 This technique also reduces the traumatic avulsion of the tissues, enhances postoperative recovery, decreases traumatic bruising, and augments skin sensitivity and draping. 6 Nonetheless, the risk of epidermolysis persists in patients with severe lymphedema and epidermal skin changes who are treated with aggressive liposuction ( Figs. 4 and 5 ). Therefore, a thorough patient selection is always mandatory.
Fig. 4

Case of combined lymphovenous anastomosis (LVA) and suction-assisted lipectomy. ( A ) Preoperative photograph. ( B ). Postoperative photograph on the second day of follow-up. ( C ) Zone of epidermolysis on postoperative day 21.

Fig. 5

Combined Charles, Homan, and VLNT procedure. ( A ) Preoperative photograph. ( B ) Intraoperative photograph before skin grafting. ( C ) Immediate postoperative photograph. ( D ) Postoperative photograph at 1 week of follow-up with a Pseudomonas infection and zones of skin graft loss. ( E ) Picture during follow-up in postoperative year 3 showing complete resolution of lymphedema.

Combined Charles, Homan, and VLNT procedure. ( A ) Preoperative photograph. ( B ) Intraoperative photograph before skin grafting. ( C ) Immediate postoperative photograph. ( D ) Postoperative photograph at 1 week of follow-up with a Pseudomonas infection and zones of skin graft loss. ( E ) Picture during follow-up in postoperative year 3 showing complete resolution of lymphedema.

Radical Reduction with Perforator Preservation

We have been including RRPP (an excisional procedure following microsurgical principles) in recent years in combination with VLNT when liposuction is not an option, obtaining promising results in patients with end-stage lymphedema but mild fibrosis and minimal trophic skin changes. 38 The markings on the leg consist of two anterior and posterior ellipses positioned obliquely and parallel to each other, which provide good access to the subcutaneous layer around the circumference of the leg. It is also recommended to include a skin bridge with a minimum width of 4 cm that separates the ellipses, both anteriorly and posteriorly, as this prevents full skin necrosis at the middle of the leg. 38 64 During subcutaneous excision, fat is tangentially excised until a 0.5-cm-thick flap is attained. Using these parameters, flap necrosis is avoided and wound healing is optimized. 38 64 Finally, the senior author also recommends preserving a 1.5- to 2-cm “cuff” of fat around the two main skin flaps' perforators (to the medial and lateral) to ensure adequate skin perfusion. For the upper extremity, as we reported in previous studies, the landmarks that represent the major fasciocutaneous branches of the radial and ulnar artery should be avoided during the initial dissection. 38 65 For the dorsal aspect of the forearm, a posterior ellipse is designed at the central area along its longitudinal axis. 38 65 Ultimately, loupe magnification is recommended to identify the vascular branches during elevation of the medial and lateral skin flaps; in this way, the bipedicle design of the medial and lateral skin flaps ensures blood supply from above the elbow and below the wrist. 38 65

Homan Procedure

While aesthetically more favorable than the Charles procedure, the final outcomes of the Homan procedure is reliant on the amount of tissue removed and a sustained postoperative compression garment use. 37 Lee et al reported a series of 33 patients who underwent this treatment. The procedure was initially successful in 28 patients, but only 6 were able to maintain an optimum limb circumference at a 2-year follow-up. 99 In our experience, the Homan procedure is reserved for the upper thigh as it achieves a tension-free closure and provides a smooth-contoured transition from the skin-grafted area to the rest of the body when used in conjunction with the Charles procedure (in a combination referred to as CHAHOVA; Fig. 5 ). 37 66 Consequently, this procedure is usually avoided in the leg as there is usually a higher tension during closure and a high risk of skin flap necrosis.

Charles Procedure

The Charles procedure may be the only surgical option in patients with end-stage lower extremity lymphedema and frequent episodes of cellulitis. 100 However, despite its high success rate, latent complications have been reported such as poor cosmetic results, recurrence of lymphedema (especially at the foot and ankle), skin graft loss, infections, and toe amputation ( Fig. 5 ). 10 60 61 62 67 The modified Charles procedure consists of preserving the lesser saphenous vein along with its superficial branch on the dorsum of the foot. Therefore, the superficial venous system provides an additional recipient vein for VLNT and maximizes lymphatic drainage. In a previous clinical study of the CHAHOVA technique, 24 patients who presented with long-lasting unilateral late-stage lower extremity lymphedema underwent VLNT in conjunction with the Charles and Homan procedures achieving an average circumference reduction rate of 98.1%. 37 67 When possible, intraoperative tourniquet control can help avoid complications related to intraoperative blood loss, therefore decreasing the requirement for blood transfusion. 100 Van der Walt et al presented a modified Charles procedure, applying 5 to 7 days of negative-pressure dressings following the initial debulking surgery before delayed skin grafting. 10 In this series, three of nine patients required regrafting and 88% required blood transfusions, especially when tourniquet use was not done appropriately. The results showed robust functional improvements in quality of life and a high overall satisfaction rate. 10 Finally, several modest adjustments have been described that minimize the complication of the Charles procedure. For instance, long sheets of skin grafts circumferentially placed in an overlapping manner to decrease the number of ridges and avoid gaps are recommended. 37 66 Furthermore, immediate postoperative leg elevation and compliance with a rigorous physiotherapy regimen yield much more predictable outcomes of skin grafting. 37

Conclusion

Despite the numerous surgical alternatives available to reduce the limb volume and reinstate functionality, lymphedema continues to represent a challenging condition for surgeons. In this matter, a careful selection of patients and surgical approach, compliance with conservative therapy, and an experienced surgeon with an adequate understanding of the lymphatic system can help maximize safety during the surgical management of lymphedema. Nonetheless, complications are inherent to surgical interventions, and further studies reporting the complications of lymphatic surgery are required to improve outcomes.
  99 in total

1.  Surgical treatment of secondary lymphedema of the upper limb by stepped microsurgical lymphaticovenous anastomoses.

Authors:  Marie-Anne Poumellec; Rémi Foissac; Marianne Cegarra-Escolano; Emmanuel Barranger; Tarik Ihrai
Journal:  Breast Cancer Res Treat       Date:  2017-01-12       Impact factor: 4.872

2.  Omentoplasty in the management of filarial lymphoedema.

Authors:  C Binoy; Y G Rao; N Ananthakrishnan; V Kate; J Yuvaraj; S P Pani
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 May-Jun       Impact factor: 2.184

3.  Microsurgical transfer of the greater omentum in the treatment of canine obstructive lymphoedema.

Authors:  B M O'Brien; M J Hickey; J V Hurley; E Dvir; R K Khazanchi; W C Pederson; J J Pribaz
Journal:  Br J Plast Surg       Date:  1990-07

4.  A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer.

Authors:  Dimitrios Dionyssiou; Efterpi Demiri; Antonis Tsimponis; Alexandros Sarafis; Vasillios Mpalaris; Georgia Tatsidou; Georgios Arsos
Journal:  Breast Cancer Res Treat       Date:  2016-02-19       Impact factor: 4.872

5.  Autotransplantation of the greater omentum in the treatment of chronic lymphedema.

Authors:  Y S Egorov; K G Abalmasov; V V Ivanov; Y A Abramov; R M Gainulin; S S Chatterjee; B E Khussainov
Journal:  Lymphology       Date:  1994-09       Impact factor: 1.286

Review 6.  Latissimus dorsi flap with vascularized lymph node transfer for lymphedema treatment: Technique, outcomes, indications and review of literature.

Authors:  Amir Inbal; Chad M Teven; David W Chang
Journal:  J Surg Oncol       Date:  2016-12-12       Impact factor: 3.454

7.  Radical reduction of lymphedema with preservation of perforators.

Authors:  Christopher J Salgado; Samir Mardini; Stefano Spanio; Wen-Ruay Tang; Paolo Sassu; Hung-Chi Chen
Journal:  Ann Plast Surg       Date:  2007-08       Impact factor: 1.539

8.  Complications of autologous lymph-node transplantation for limb lymphoedema.

Authors:  S Vignes; M Blanchard; A Yannoutsos; M Arrault
Journal:  Eur J Vasc Endovasc Surg       Date:  2013-01-08       Impact factor: 7.069

9.  Liposuction Gives Complete Reduction of Arm Lymphedema following Breast Cancer Treatment-A 5-year Prospective Study in 105 Patients without Recurrence.

Authors:  Mattias Hoffner; Karin Ohlin; Barbro Svensson; Jonas Manjer; Emma Hansson; Thomas Troëng; Håkan Brorson
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-08-16

Review 10.  Surgical Management of Lower Extremity Lymphedema: A Comprehensive Review.

Authors:  Pedro Ciudad; M Diya Sabbagh; Mouchammed Agko; Tony C T Huang; Oscar J Manrique; Carmen Román L; Cesar Reynaga; Ricardo Delgado; Michele Maruccia; Hung-Chi Chen
Journal:  Indian J Plast Surg       Date:  2019-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.